新闻Selecta Biosciences, Inc. acquires Cartesian Therapeutics, Inc..Selecta Biosciences Inc. (Nasdaq: SELB) said Monday morning it had acquired Gaithersburg, Maryland-based Cartesian Therapeutics Inc., a developer of treatments for autoimmune diseases.
新闻Selecta Biosciences, Inc. receives financing of $60.3M in private financing.In connection with the merger, Selecta announced a $60.25 million private financing led by Timothy A. Springer, Ph.D., member of the Selecta Board of Directors.
新闻Selecta Biosciences, Inc. partnered with Cartesian Therapeutics, Inc. on Nov 13th '23.Selecta Biosciences announces merger with Cartesian Therapeutics.
